Lyell Immunopharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARCH VENTURE MANAGEMENT, LLC | 08/14/2026 | 3.25 M | $45.53 M | 0.00% | 13.90% |
| GSK PLC | 08/13/2026 | 1.51 M | $21.25 M | 0.00% | 6.47% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 786.77 K | $11.05 M | 9.55% | 3.37% |
| ORLAND PROPERTIES LTD | 08/05/2026 | 754.70 K | $10.60 M | 0.00% | 3.23% |
| BLACKROCK, INC. | 08/07/2026 | 724.34 K | $10.18 M | 277.62% | 3.10% |
| ALMITAS CAPITAL LLC | 08/17/2026 | 581.41 K | $8.17 M | 0.62% | 2.49% |
| FORESITE CAPITAL MANAGEMENT V, LLC | 08/14/2026 | 476.39 K | $6.69 M | -0.15% | 2.04% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 367.47 K | $5.16 M | -19.92% | 1.57% |
| OPALEYE MANAGEMENT INC. | 08/14/2026 | 344.03 K | $4.83 M | 334.94% | 1.47% |
| VENBIO PARTNERS LLC | 08/14/2026 | 337.70 K | $4.74 M | 0.00% | 1.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 310.64 K | $4.37 M | 86.03% | 1.33% |
| ALPHABET INC. | 08/07/2026 | 293.26 K | $4.12 M | 0.00% | 1.26% |
| STATE STREET CORP | 08/07/2026 | 185.32 K | $2.60 M | 155.54% | 0.79% |
| SC CHINA HOLDING LTD | 08/13/2026 | 152.30 K | $2.14 M | 0.00% | 0.65% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 130.19 K | $1.83 M | 11.84% | 0.56% |
| NORTHERN TRUST CORP | 08/13/2026 | 118.50 K | $1.66 M | 291.35% | 0.51% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 110.53 K | $1.55 M | 100.56% | 0.47% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 107.57 K | $1.51 M | 25.12% | 0.46% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 107.57 K | $1.51 M | 100.00% | 0.46% |
| MARSHALL WACE, LLP | 08/13/2026 | 106.30 K | $1.49 M | -28.43% | 0.46% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2026 | 105.00 K | $1.48 M | 2.94% | 0.45% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 93.10 K | $1.31 M | 7.10% | 0.40% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 91.89 K | $1.29 M | 299.27% | 0.39% |
| MIC CAPITAL MANAGEMENT UK LLP | 08/10/2026 | 87.03 K | $1.22 M | 0.00% | 0.37% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 86.78 K | $1.22 M | -24.20% | 0.37% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 68.32 K | $957.07 K | 42.66% | 0.29% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 59.75 K | $836.00 K | 100.00% | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 52.93 K | $743.62 K | 356.86% | 0.23% |
| JANE STREET GROUP, LLC | 08/14/2026 | 46.01 K | $646.46 K | -27.99% | 0.20% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 42.32 K | $594.62 K | 119.35% | 0.18% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 41.08 K | $577.19 K | 0.00% | 0.18% |
| MORGAN STANLEY | 08/13/2026 | 37.05 K | $520.55 K | -34.02% | 0.16% |
| HRT FINANCIAL LP | 08/14/2026 | 36.58 K | $513.00 K | 100.00% | 0.16% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 30.66 K | $431.00 K | 133.52% | 0.13% |
| CANADA PENSION PLAN INVESTMENT BOARD | 08/14/2026 | 29.41 K | $413.23 K | 0.00% | 0.13% |
| GSA CAPITAL PARTNERS LLP | 08/06/2026 | 26.23 K | $368.00 K | 100.00% | 0.11% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 26.08 K | $366.42 K | 22.49% | 0.11% |
| UBS GROUP AG | 08/13/2026 | 25.98 K | $365.05 K | -18.33% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 25.90 K | $363.90 K | 100.00% | 0.11% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 24.67 K | $346.66 K | 100.00% | 0.11% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 24.54 K | $344.79 K | 53.65% | 0.11% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 21.96 K | $308.48 K | 9.11% | 0.09% |
| CLEARSTEAD ADVISORS, LLC | 08/06/2026 | 19.96 K | $280.41 K | -50.00% | 0.09% |
| ENTRYPOINT CAPITAL, LLC | 08/13/2026 | 19.41 K | $272.71 K | 100.00% | 0.08% |
| CITADEL ADVISORS LLC | 09/02/2026 | 18.70 K | $262.67 K | -95.10% | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 18.00 K | $252.90 K | 0.00% | 0.08% |
| CITADEL ADVISORS LLC | 09/02/2026 | 17.90 K | $251.50 K | 100.00% | 0.08% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2026 | 17.88 K | $251.14 K | -14.06% | 0.08% |
| CITADEL ADVISORS LLC | 09/02/2026 | 17.00 K | $238.85 K | 41.67% | 0.07% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 08/13/2026 | 16.15 K | $226.84 K | 100.00% | 0.07% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lyell Immunopharma Inc institutional Ownership - FAQ's
During the previous two years, 117 institutional investors and hedge funds held shares of Lyell Immunopharma Inc. The most heavily invested institutionals were:
ARCH Venture Management, LLC: 3.25 M
GSK PLC: 1.51 M
VANGUARD CAPITAL MANAGEMENT LLC: 786,774
Orland Properties Ltd: 754,698
BlackRock, Inc.: 724,342
Almitas Capital LLC: 581,407
51.75% of Lyell Immunopharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 52.20 M shares in the last 24 months. This purchase volume represents approximately $1.33 B in transactions.